

浏览全部资源
扫码关注微信
1.河南中医药大学 第一附属医院,郑州 450046
2.河南中医药大学 第一临床医学院,郑州 450046
Received:26 April 2025,
Revised:2025-05-20,
Accepted:10 July 2025,
Online First:11 July 2025,
Published:05 August 2026
移动端阅览
马萌萌,关徐涛,孙士玲.经典名方六味地黄丸的研究进展及质量标志物预测[J].中国实验方剂学杂志,2026,32(15):317-329.
MA Mengmeng,GUAN Xutao,SUN Shiling.A Review of Classical Formula Liuwei Dihuangwan and Quality Marker Prediction[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(15):317-329.
马萌萌,关徐涛,孙士玲.经典名方六味地黄丸的研究进展及质量标志物预测[J].中国实验方剂学杂志,2026,32(15):317-329. DOI: 10.13422/j.cnki.syfjx.20252195.
MA Mengmeng,GUAN Xutao,SUN Shiling.A Review of Classical Formula Liuwei Dihuangwan and Quality Marker Prediction[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(15):317-329. DOI: 10.13422/j.cnki.syfjx.20252195.
六味地黄丸(LWDH)首见于《小儿药证直诀》,由熟地黄、山茱萸、山药、泽泻、牡丹皮、茯苓6味药组成,是滋阴补肾的经典名方之一。LWDH现收录于2025年版《中华人民共和国药典》,其制备过程严格选用优质原料药材,并基于现代化制药技术进行工艺优化,有效保留了药物中的活性成分,主要含有机酸类、萜类、黄酮类和苷类等化合物。现代研究表明LWDH具有保护肾脏、抗氧化、抗肿瘤、调节免疫、调节脂质代谢等药理作用,多用于治疗肾脏疾病、代谢性疾病、妇科疾病、骨科疾病、肿瘤疾病、儿科疾病等疾病。该文从化学成分、药理作用及现代临床应用等方面对LWDH的研究进展进行综述,并依照质量标志物(Q-Marker)的概念对LWDH的Q-Marker进行预测,确定地黄苷D、毛蕊花糖苷、23-乙酰泽泻醇B、23-乙酰泽泻醇C、丹皮酚、茯苓酸、尿囊素、马钱苷、莫诺苷可以作为该方的潜在Q-Marker,为后续复方研究及质量控制提供科学依据。
The formula, Liuwei Dihuangwan (LWDH), first recorded in
Key to Therapeutics of Children's Diseases
(
Xiao Er Yao Zheng Zhi Jue
), is composed of six herbal medicines: Rehmanniae Radix Praeparata, Corni Fructus, Dioscoreae Rhizoma, Alismatis Rhizoma, Moutan Cortex, and Poria. It is one of the classic formulas for nourishing yin and tonifying the kidney. It has been included in the 2020 edition of the
Pharmacopoeia of the People's Republic of China
. The manuf
acturing process employs strictly selected high-quality medicinal materials and is optimized using modern pharmaceutical technologies, thereby effectively preserving the active constituents of the formula. The formula mainly contain organic acids, terpenoids, flavonoids, glycosides, and other compounds. Modern studies have demonstrated that LWDH possess a variety of pharmacological activities, including renal protection, antioxidant, antitumor, immunomodulatory, and lipid metabolism-regulating effects, and are widely used in the treatment of renal diseases, metabolic diseases, gynecological diseases, orthopedic diseases, neoplastic diseases, and pediatric diseases. This review summarizes the research progress on LWDH with respect to chemical constituents, pharmacological effects, and modern clinical applications. Furthermore, based on the concept of quality markers (Q-Markers), the potential Q-Markers of LWDH were predicted. Rehmannioside D, verbascoside, alisol B 23-acetate, alisol C 23-acetate, paeonol, pachymic acid, allantoin, loganin, and morroniside were identified as potential Q-Markers of the formula, providing a scientific basis for subsequent studies on this compound prescription and its quality control.
钱乙 . 小儿药证直诀 [M]. 北京 : 人民卫生出版社 , 2006 : 42 .
QIAN Y . Xiaoer Yaozheng Zhijue [M]. Beijing : People’s Medical Publishing House , 2006 : 42 .
刘相 , 杨璧英 , 胡爽 , 等 . 肾劳病源流考 [J]. 上海中医药杂志 , 2025 , 59 ( 2 ): 36 - 40 .
LIU X , YANG B Y , HU S , et al . Textual research on the origin and development of Shenlao disease [J]. Shanghai J Tradit Chin Med , 2025 , 59 ( 2 ): 36 - 40 .
戚瑜清 , 于彦威 , 郭智超 , 等 . 补阴名方六味地黄丸的源流考察 [J]. 浙江中医药大学学报 , 2025 , 49 ( 3 ): 345 - 350 .
QI Y Q , YU Y W , GUO Z C , et al . Textual research on the origin and development of Liuwei Dihuang pills,a famous yYin-nourishing prescription [J]. J Zhejiang Chin Med Univ , 2025 , 49 ( 3 ): 345 - 350 .
王旭 , 陈诗琦 , 张翔 , 等 . 六味地黄丸临床应用进展 [J]. 中国现代医生 , 2023 , 61 ( 20 ): 126 - 130 .
WANG X , CHEN S Q , ZHANG X , et al . Advances in clinical application of Liuwei Dihuang pills [J]. Chin Mod Doctor , 2023 , 61 ( 20 ): 126 - 130 .
赵志芬 , 张蒙蒙 , 翟文生 , 等 . 六味地黄丸治疗糖尿病肾病的药理、临床及实验研究进展 [J]. 时珍国医国药 , 2025 , 36 ( 1 ): 132 - 136 .
ZHAO Z F , ZHANG M M , ZHAI W S , et al . Advances in pharmacological,clinical and experimental research of Liuwei Dihuang pills in treating diabetic nephropathy [J]. Lishizhen Med Mater Med Res , 2025 , 36 ( 1 ): 132 - 136 .
吕文君 , 丁静贤 , 张沁瑶 , 等 . 六味地黄丸联合羟苯磺酸钙治疗糖尿病肾病疗效观察 [J]. 湖北中医药大学学报 , 2025 , 27 ( 2 ): 35 - 38 .
LYU W J , DING J X , ZHANG Q Y , et al . Efficacy of Liuwei Dihuang pills combined with calcium dobesilate in diabetic nephropathy [J]. J Hubei Univ Chin Med , 2025 , 27 ( 2 ): 35 - 38 .
吴锦美 . 补肾利湿活血法治疗慢性肾小球肾炎临床研究 [J]. 中华中医药学刊 , 2015 , 33 ( 1 ): 227 - 229 .
WU J M . Clinical study on Bushen Lishi Huoxue therapy for chronic glomerulonephritis [J]. Chin Arch Tradit Chin Med , 2015 , 33 ( 1 ): 227 - 229 .
徐君 , 张晓俊 , 李森丽 , 等 . 六味地黄丸联合恩格列净治疗2型糖尿病的成本-效果分析 [J]. 吉林医学 , 2024 , 45 ( 11 ): 2738 - 2740 .
XU J , ZHANG X J , LI S L , et al . Cost-effectiveness analysis of Liuwei Dihuang pills combined with empagliflozin for type 2 diabetes [J]. Jilin Med J , 2024 , 45 ( 11 ): 2738 - 2740 .
谢文艳 , 陈金水 . 六味地黄丸加减汤治疗高血压病的疗效观察 [J]. 内蒙古中医药 , 2015 , 34 ( 9 ): 37 - 38 .
XIE W Y , CHEN J S . Clinical efficacy observation of modified Liuwei Dihuang decoction in treating hypertension [J]. Inner Mongolia J Tradit Chin Med , 2015 , 34 ( 9 ): 37 - 38 .
钱志国 . 六味地黄丸对2型糖尿病合并高脂血症的疗效 [J]. 中医临床研究 , 2013 , 5 ( 19 ): 20 - 21 .
QIAN Z G . Efficacy of Liuwei Dihuang pills in type 2 diabetes with hyperlipidemia [J]. Clin J Chin Med , 2013 , 5 ( 19 ): 20 - 21 .
吴喜娟 . 六味地黄丸联合雌孕激素治疗围绝经期综合征临床观察 [J]. 实用中医药杂志 , 2022 , 38 ( 12 ): 2137 - 2139 .
WU X J . Clinical observation of Liuwei Dihuang pills combined with estrogen-progestin for perimenopausal syndrome [J]. J Pract Tradit Chin Med , 2022 , 38 ( 12 ): 2137 - 2139 .
廖贵凤 , 韦欣宏 , 罗志娟 . 罗志娟治疗多囊卵巢综合征所致闭经经验 [J]. 实用中医药杂志 , 2017 , 33 ( 6 ): 725 - 726 .
LIAO G F , WEI X H , LUO Z J . LUO Zhijuan's experience in treating PCOS-induced amenorrhea [J]. J Pract Tradit Chin Med , 2017 , 33 ( 6 ): 725 - 726 .
龚竹韵 . 六味地黄丸加减治疗月经不调临床研究 [J]. 中医药临床杂志 , 2018 , 30 ( 8 ): 1517 - 1519 .
GONG Z Y . Clinical study of modified Liuwei Dihuang pills for menstrual disorders [J]. Clin J Chin Med , 2018 , 30 ( 8 ): 1517 - 1519 .
王梅生 , 周俊英 , 王乐荣 . 针灸联合六味地黄丸序贯治疗肾精亏虚型早发性卵巢功能不全临床观察 [J]. 中国中医药现代远程教育 , 2024 , 22 ( 13 ): 110 - 112 .
WANG M S , ZHOU J Y , WANG L R . Sequential therapy of acupuncture and Liuwei Dihuang pills for premature ovarian insufficiency(kidney essence deficiency) [J]. Chin Med Mod Distance Educ China , 2024 , 22 ( 13 ): 110 - 112 .
魏光成 , 张智龙 , 张馨文 , 等 . 基于整合证据链和GRADE的12种常用中成药治疗骨质疏松症证据评价 [J]. 中国中药杂志 , 2025 , 50 ( 15 ): 4372 - 4385 .
WEI G C , ZHANG Z L , ZHANG X W , et al . Evidence evaluation of 12 Chinese patent medicines for osteoporosis based on evidence chain and GRADE system [J]. China J Chin Mater Med , 2025 , 50 ( 15 ): 4372 - 4385 .
宋文涛 . 六味地黄丸联合美金刚对阿尔茨海默症认知功能及QOL-AD评分的影响 [J]. 内蒙古医学杂志 , 2021 , 53 ( 9 ): 1103 - 1105 .
SONG W T . Effects of Liuwei Dihuang pills combined with memantine on cognitive function and QOL-AD in Alzheimer's disease [J]. Inner Mongolia Med J , 2021 , 53 ( 9 ): 1103 - 1105 .
刘梓燊 , 郑瑛瑛 , 袁梦琪 , 等 . 基于“肝肾同源”理论防治乳腺癌内分泌治疗相关性骨质疏松症的思路探讨 [J]. 广州中医药大学学报 , 2025 , 42 ( 2 ): 293 - 297 .
LIU Z S , ZHENG Y Y , YUAN M Q , et al . Prevention and treatment of endocrine therapy-related osteoporosis in breast cancer based on "liver-kidney homology" theory [J]. J Guangzhou Univ Tradit Chin Med , 2025 , 42 ( 2 ): 293 - 297 .
荣红国 , 巩舒扬 , 张馨月 , 等 . 六味地黄丸在儿科中的历史沿革与现代临床应用分析 [J]. 中医药学报 , 2025 , 53 ( 1 ): 57 - 61 .
RONG H G , GONG S Y , ZHANG X Y , et al . Historical evolution and modern clinical application of Liuwei Dihuang pills in pediatrics [J]. Acta Chin Med Pharmacol , 2025 , 53 ( 1 ): 57 - 61 .
刘昌孝 , 陈士林 , 肖小河 , 等 . 中药质量标志物(Q-Marker):中药产品质量控制的新概念 [J]. 中草药 , 2016 , 47 ( 9 ): 1443 - 1457 .
LIU C X , CHEN S L , XIAO X H , et al . Quality marker (Q-Marker) of traditional Chinese medicine:A new concept for quality control of Chinese medicinal products [J]. Chin Tradit Herb Drugs , 2016 , 47 ( 9 ): 1443 - 1457 .
高如汐 , 王凡一 , 刘想 , 等 . 熟地黄历史沿革及其化学成分和药理作用的研究进展 [J]. 辽宁中医药大学学报 , 2025 , 27 ( 5 ): 167 - 176 .
GAO R X , WANG F Y , LIU X , et al . Research progress on historical evolution,chemical constituentsand pharmacological effects of Rehmanniae Radix Praeparata [J]. J Liaoning Univ Tradit Chin Med , 2025 , 27 ( 5 ): 167 - 176 .
许平翠 , 朱赋健 , 郑纯威 , 等 . 基于HPLC多波长融合指纹图谱及谱效关系的熟地黄活性成分研究 [J]. 中国现代应用药学 , 2022 , 39 ( 22 ): 2901 - 2907 .
XU P C , ZHU F J , ZHENG C W , et al . Study on active components of Rehmanniae Radix Praeparatabased on HPLC multi-wavelength fusion fingerprint and spectrum-effect relationship [J]. Chin J Mod Appl Pharm , 2022 , 39 ( 22 ): 2901 - 2907 .
吴晓云 , 王迅 , 王丹丹 , 等 . 基于顶空-气相色谱-离子迁移谱法的地黄与酒炖熟地黄及蒸制熟地黄挥发性化学成分表征及差异性研究 [J]. 中国现代应用药学 , 2024 , 41 ( 16 ): 2228 - 2236 .
WU X Y , WANG X , WANG D D , et al . Characterization and differentiation of volatile chemical components in Rehmanniae Radix and its wine-steamed and steamed products by HS-GC-IMS [J]. Chin J Mod Appl Pharm , 2024 , 41 ( 16 ): 2228 - 2236 .
吕锦锦 , 张靖柯 , 李孟 , 等 . 熟地黄化学成分研究 [J]. 中药材 , 2021 , 44 ( 7 ): 1645 - 1650 .
LYU J J , ZHANG J K , LI M , et al . Study on chemical constituents of Rehmanniae Radix Praeparata [J]. J Chin Med Mater , 2021 , 44 ( 7 ): 1645 - 1650 .
李红彬 等 , 冯庆梅 等 , 张玲霞 , 等 . 酒萸肉环烯醚萜类化学成分研究 [J]. 中国中药杂志 , 2022 , 47 ( 5 ): 1273 - 1278 .
LI H B , FENG Q M , ZHANG L X , et al . Study on iridoid glycosides from Corni Fructus [J]. China J Chin Mater Med , 2022 , 47 ( 5 ): 1273 - 1278 .
张立强 , 单国顺 , 洪艺丹 , 等 . 基于UPLC-Q-TOF-MS和UPLC-QqQ-MS/MS的山茱萸不同炮制品化学成分定性与定量分析 [J]. 中国中药杂志 , 2025 , 50 ( 8 ): 2145 - 2158 .
ZHANG L Q , SHAN G S , HONG Y D , et al . Qualitative and quantitative analysis of chemical constituents in different processed products of Corni Fructus by UPLC-Q-TOF-MS and UPLC-QqQ-MS/MS [J]. China J Chin Mater Med , 2025 , 50 ( 8 ): 2145 - 2158 .
向俊 , 范倩 , 陈雪冰 , 等 . UPLC-Q-TOF-MS/MS联和GNPS技术对山茱萸及其炮制品的化学成分差异研究 [J]. 中草药 , 2023 , 54 ( 24 ): 7989 - 8006 .
XIANG J , FAN Q , CHEN X B , et al . Study on chemical composition differences between Corni Fructus and its processed products by UPLC-Q-TOF-MS/MS combined with GNPS technology [J]. Chin Tradit Herb Drugs , 2023 , 54 ( 24 ): 7989 - 8006 .
葛成成 , 陈桂花 , 郑夏静 , 等 . 山药释名考证 [J]. 中国医药导报 , 2017 , 14 ( 16 ): 71 - 73 .
GE C C , CHEN G H , ZHENG X J , et al . Textual research on the name of Dioscoreae Rhizoma [J]. China Med Herald , 2017 , 14 ( 16 ): 71 - 73 .
XUE H Y , LI J R , LIU Y G , et al . Optimization of the ultrafiltration-assisted extraction of Chinese yam polysaccharide using response surface methodology and its biological activity [J]. Int J Biol Macromol , 2019 , 121 : 1186 - 1193 .
Sun J , Gan C , Huang J , et al . Determination of triterpenoids and phenolic acids from Sanguisorba officinalis L by HPLC-ELSD and its application [J]. Molecules , 2021 , 26 ( 15 ): 4505 .
严林 , 欧则民 , 王艳静 , 等 . 基于UPLC-Q-TOF-MS的泽泻盐制前后血清药物化学比较分析 [J]. 中国实验方剂学杂志 , 2023 , 29 ( 23 ): 122 - 130 .
YAN L , OU Z M , WANG Y J , et al . Comparative serum pharmacochemistry analysis of Alismatis Rhizoma before and after salt processing based on UPLC-Q-TOF-MS [J]. Chin J Exp Tradit Med Form , 2023 , 29 ( 23 ): 122 - 130 .
张春彬 , 李琳 , 康茜 , 等 . HPLC一测多评法测定泽泻饮片中6种三萜类成分的含量 [J]. 华西药学杂志 , 2023 , 38 ( 1 ): 79 - 83 .
ZHANG C B , LI L , KANG X , et al . Determination of six triterpenoids in Alismatis Rhizoma by HPLC-QAMS [J]. West China J Pharm Sci , 2023 , 38 ( 1 ): 79 - 83 .
彭华胜 , 王德群 , 彭代银 , 等 . 药用牡丹基原的考证和调查 [J]. 中国中药杂志 , 2017 , 42 ( 9 ): 1632 - 1636 .
PENG H S , WANG D Q , PENG D Y , et al . Textual research and investigation on the origin of medicinal Paeonia suffruticosa [J]. China J Chin Mater Med , 2017 , 42 ( 9 ): 1632 - 1636 .
胡云飞 , 裴月梅 , 吴虹 , 等 . 基于UPLC-Q-TOF-MS技术研究不同产地牡丹皮药材化学成分的差异 [J]. 中草药 , 2016 , 47 ( 17 ): 2984 - 2992 .
HU Y F , PEI Y M , WU H , et al . Study on chemical composition differences of Moutan Cortex from different habitats based on UPLC-Q-TOF-MS technology [J]. Chin Tradit Herb Drugs , 2016 , 47 ( 17 ): 2984 - 2992 .
曹杰楠 , 王媛媛 , 夏梦莹 , 等 . 基于指纹图谱及多元统计分析评价牡丹皮的质量 [J]. 中药材 , 2021 , 44 ( 3 ): 644 - 648 .
CAO J N , WANG Y Y , XIA M Y , et al . Quality evaluation of Moutan Cortex based on fingerprint and multivariate statistical analysis [J]. J Chin Med Mater , 2021 , 44 ( 3 ): 644 - 648 .
陆彩侠 , 孔垂皓 , 唐旭 , 等 . 牡丹皮正丁醇部位化学成分研究 [J]. 天然产物研究与开发 , 2024 , 36 ( 10 ): 1714 - 1720 .
LU C X , KONG C H , TANG X , et al . Chemical constituents from n-butanol fraction of Moutan Cortex [J]. Nat Prod Res Dev , 2024 , 36 ( 10 ): 1714 - 1720 .
陈蓉 , 张超 , 顾倩 , 等 . 柱前衍生-HPLC法同时测定不同产地茯苓中18种氨基酸含量 [J]. 药物分析杂志 , 2017 , 37 ( 2 ): 297 - 303 .
CHEN R , ZHANG C , GU Q , et al . Simultaneous determination of 18 amino acids in Poria from different habitats by pre-column derivatization-HPLC [J]. Chin J Pharm Anal , 2017 , 37 ( 2 ): 297 - 303 .
张丹丹 , 万文标 , 尧青 , 等 . UPLC-Q-TOF-MS/MS结合网络药理学及实验验证探究茯苓水提物降血糖的机制 [J]. 中国中药杂志 , 2025 , 50 ( 14 ): 3980 - 3989 .
ZHANG D D , WAN W B , YAO Q , et al . Exploring the hypoglycemic mechanism of Poria water extract by UPLC-Q-TOF-MS/MS combined with network pharmacology and experimental verification [J]. China J Chin Mater Med , 2025 , 50 ( 14 ): 3980 - 3989 .
陈素娥 , 孙红 , 朱琳 , 等 . 茯苓药材高效液相色谱指纹图谱及多指标成分定量研究 [J]. 中南药学 , 2020 , 18 ( 9 ): 1507 - 1512 .
CHEN S E , SUN H , ZHU L , et al . HPLC fingerprint and multi-component quantitative analysis of Poria [J]. Central South Pharm , 2020 , 18 ( 9 ): 1507 - 1512 .
赵婷秀 , 曹迪 , 茆文莉 , 等 . HPLC-QTOF-MS分析六味地黄丸不同部位的化学成分 [J]. 中药新药与临床药理 , 2018 , 29 ( 4 ): 489 - 496 .
ZHAO T X , CAO D , MAO W L , et al . Chemical composition analysis of different parts of Liuwei Dihuang pill by HPLC-QTOF-MS [J]. Tradit Chin Drug Res Clin Pharm , 2018 , 29 ( 4 ): 489 - 496 .
邱琦 , 徐艳明 , 薛傲 , 等 . 基于UPLC-Q-TOF-MS技术及网络药理学方法探讨六味地黄丸入脑成分改善 D -gal模型大鼠学习记忆能力的作用机制 [J]. 中国医院用药评价与分析 , 2022 , 22 ( 11 ): 1294 - 1301 .
QIU Q , XU Y M , XUE A , et al . Mechanism of Liuwei Dihuang pill's brain-entering components in improving learning and memory ability of D -gal model rats based on UPLC-Q-TOF-MS technology and network pharmacology [J]. Eval Anal Drug-Use Hosp China , 2022 , 22 ( 11 ): 1294 - 1301 .
XU Z J , SHU S , LI Z J , et al . Liuwei Dihuang pill treats diabetic nephropathy in rats by inhibiting of TGF-beta/SMADS,MAPK,and NF- ĸ B and upregulating expression of cytoglobin in renal tissues [J]. Medicine (Baltimore) , 2017 , 96 ( 3 ): e5879 .
张瑞义 , 舒适 , 李志杰 , 等 . 六味地黄丸干预阿霉素小鼠肾病对p38MAPK及NF- κ B信号通路的影响 [J]. 数理医药学杂志 , 2017 , 30 ( 7 ): 949 - 953 .
ZHANG R Y , SHU S , LI Z J , et al . Effects of Liuwei Dihuang pills on p38MAPK and NF- κ B signaling pathways in adriamycin-induced nephropathy in mice [J]. J Math Med , 2017 , 30 ( 7 ): 949 - 953 .
李旭华 , 彭亚军 , 盛望 , 等 . 六味地黄丸干预FGF23/Klotho轴对慢性肾衰竭钙磷代谢紊乱模型大鼠的影响 [J]. 中医药导报 , 2024 , 30 ( 10 ): 36 - 40 .
LI X H , PENG Y J , SHENG W , et al . Effects of Liuwei Dihuang pills on FGF23/Klotho axis in chronic renal failure model rats with calcium-phosphorus metabolism disorder [J]. Guide J Tradit Chin Med Pharm , 2024 , 30 ( 10 ): 36 - 40 .
丁文君 , 陈彩英 , 沈明霞 , 等 . 中药复方基于Wnt/ β -catenin信号通路调控糖尿病肾病研究进展 [J]. 河南中医 , 2024 , 44 ( 6 ): 935 - 941 .
DING W J , CHEN C Y , SHEN M X , et al . Research progress of traditional Chinese medicine compounds in regulating diabetic nephropathy via Wnt/ β -catenin signaling pathway [J]. Henan Tradit Chin Med , 2024 , 44 ( 6 ): 935 - 941 .
李莉 . 六味地黄丸对H 2 O 2 致MC3T3-E1细胞氧化损伤的保护机制研究 [D]. 福州 : 福建中医药大学 , 2021 .
LI L . Protective mechanism of Liuwei Dihuang pills against H 2 O 2 -induced oxidative damage in MC3T3-E1 cells [D]. Fuzhou : Fujian University of Traditional Chinese Medicine , 2021 .
李宏元 , 杨柳 , 靳宪辉 . 缺氧诱导因子与骨稳态失衡类疾病的相关性 [J]. 中国组织工程研究 , 2022 , 26 ( 33 ): 5393 - 5399 .
LI H Y , YANG L , JIN X H . Correlation between hypoxia-inducible factors and bone homeostasis imbalance diseases [J]. Chin J Tissue Eng Res , 2022 , 26 ( 33 ): 5393 - 5399 .
BOHDANOWICZ M , COSÍO G , BACKER J M , et al . Class I and class Ⅲ phosphoinositide 3-kinases are required for actin polymerization that propels phagosomes [J]. J Cell Biol , 2010 , 191 ( 5 ): 999 - 1012 .
LI Q , XING S , CHEN Y , et al . Reasonably activating Nrf2:A long-term,effective and controllable strategy for neurodegenerative diseases [J]. Eur J Med Chem , 2020 , 185 : 111862 .
蔡菊 , 袁永 , 宋军营 , 等 . 六味地黄丸通过Nrf2/HO-1通路抗氧化应激防治阿尔茨海默病的机制研究 [J]. 世界科学技术-中医药现代化 , 2023 , 25 ( 3 ): 1002 - 1010 .
CAI J , YUAN Y , SONG J Y , et al . Mechanism of Liuwei Dihuang pills in preventing Alzheimer's disease through antioxidation via Nrf2/HO-1 pathway [J]. World Sci Technol-Mod Tradit Chin Med , 2023 , 25 ( 3 ): 1002 - 1010 .
郭澜 . 基于ERK/mTOR通路调控自噬探讨六味地黄丸减轻成骨细胞氧化应激损伤的分子机制 [D]. 福州 : 福建中医药大学 , 2022 .
GUO L . Molecular mechanism of Liuwei Dihuang pills in alleviating oxidative stress damage of osteoblasts by regulating autophagy via ERK/mTOR pathway [D]. Fuzhou : Fujian University of Traditional Chinese Medicine , 2022 .
GUO Y , PAN W , LIU S , et al . ERK/MAPK signalling pathway and tumorigenesis [J]. Exp Ther Med , 2020 , 19 ( 3 ): 1997 - 2007 .
郑里翔 , 权威 , 周露 , 等 . 六味地黄丸对三阴性乳腺癌MAP3K1、SOX2表达的影响 [J]. 中华中医药学刊 , 2022 , 40 ( 9 ): 5 - 8 .
ZHENG L X , QUAN W , ZHOU L , et al . Effects of Liuwei Dihuang pills on MAP3K1 and SOX2 expression in triple-negative breast cancer [J]. Chin Arch Tradit Chin Med , 2022 , 40 ( 9 ): 5 - 8 .
易华 , 苏俊芳 , 李雪 , 等 . 基于Cx32探讨六味地黄丸增效自杀基因抗肝癌的缝隙连接机制 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 1 ): 76 - 81 .
YI H , SU J F , LI X , et al . Gap junction mechanism of Liuwei Dihuang pills in enhancing suicide gene therapy against liver cancer based on Cx32 [J]. Chin J Exp Tradit Med Form , 2019 , 25 ( 1 ): 76 - 81 .
谢斌 , 余功 , 饶斌 , 等 . 六味地黄汤辅助环磷酰胺对荷H22小鼠肝癌组织VEGF及VEGFR2蛋白表达的影响 [J]. 江西中医药大学学报 , 2015 , 27 ( 4 ): 72 - 75 .
XIE B , YU G , RAO B , et al . Effects of Liuwei Dihuang decoction combined with cyclophosphamide on VEGF and VEGFR2 protein expression in H22 liver cancer-bearing mice [J]. J Jiangxi Univ Tradit Chin Med , 2015 , 27 ( 4 ): 72 - 75 .
饶斌 , 谢斌 , 谢雄 , 等 . 六味地黄汤辅助环磷酰胺对荷H22肝癌小鼠MMP9、NF- ĸ B表达的影响 [J]. 江西中医药大学学报 , 2015 , 27 ( 3 ): 73 - 75 .
RAO B , XIE B , XIE X , et al . Effects of Liuwei Dihuang decoction combined with cyclophosphamide on MMP9 and NF- κ B expression in H22 liver cancer-bearing mice [J]. J Jiangxi Univ Tradit Chin Med , 2015 , 27 ( 3 ): 73 - 75 .
陈娟 , 谢丽华 , 李生强 , 等 . JAK/STAT通路介导的六味地黄丸对绝经后骨质疏松症肾阴虚证的免疫调节作用 [J] 中华中医药杂志 , 2017 , 32 ( 4 ): 1747 - 1750 .
CHEN J , XIE L H , LI S Q , et al . Immunomodulatory effects of Liuwei Dihuang pills on postmenopausal osteoporosis with kidney Qin deficiency syndrome mediated by JAK/STAT pathway [J]. China J Tradit Chin Med Pharm , 2017 , 32 ( 4 ): 1747 - 1750 .
杨娟娟 , 吕忠美 , 王姝琴 . 六味地黄丸联合辛伐他汀对肾阴亏损型糖尿病肾病病人炎症免疫指标和肾纤维化的影响 [J]. 中西医结合心脑血管病杂志 , 2022 , 20 ( 12 ): 2241 - 2244 .
YANG J J , LYU Z M , WANG S Q . Effects of Liuwei Dihuang pills combined with simvastatin on inflammatory immune indexes and renal fibrosis in patients with diabetic nephropathy of kidney Yin deficiency type [J]. Chin J Integr Med Cardio-Cerebrovasc Dis , 2022 , 20 ( 12 ): 2241 - 2244 .
张文静 , 赵婷秀 , 王惠琪 , 等 . 六味地黄丸增效小鼠黑色素瘤HSV-tk/GCV自杀基因疗法的免疫机制 [J]. 中药新药与临床药理 , 2021 , 32 ( 8 ): 1120 - 1128 .
ZHANG W J , ZHAO T X , WANG H Q , et al . Immune mechanism of Liuwei Dihuang pills in enhancing HSV-tk/GCV suicide gene therapy for melanoma in mice [J]. Tradit Chin Drug Res Clin Pharm , 2021 , 32 ( 8 ): 1120 - 1128 .
樊国华 , 李悦 , 袁泽婷 , 等 . 树突状细胞在肿瘤中的研究进展 [J]. 临床肿瘤学杂志 , 2020 , 25 ( 1 ): 86 - 90 .
FAN G H , LI Y , YUAN Z T , et al . Research progress of dendritic cells in tumors [J]. Chin Clin Oncol , 2020 , 25 ( 1 ): 86 - 90 .
胡明财 , 何建华 , 章卓 , 等 . 六味地黄丸对2型糖尿病大鼠周围神经病变的影响 [J]. 中国新药杂志 , 2014 , 23 ( 3 ): 351 - 355 .
HU M C , HE J H , ZHANG Z , et al . Effects of Liuwei Dihuang pills on peripheral neuropathy in type 2 diabetic rats [J]. Chin J New Drugs , 2014 , 23 ( 3 ): 351 - 355 .
仇同同 , 邓玉春 , 王翠喆 , 等 . 游离脂肪酸通过FFAR4抑制脂肪细胞KLF15的表达和葡萄糖消耗 [J]. 石河子大学学报:自然科学版 , 2020 , 38 ( 6 ): 734 - 740 .
QIU T T , DENG Y C , WANG C Z , et al . Free fatty acids inhibit KLF15 expression and glucose consumption in adipocytes through FFAR4 [J]. J Shihezi Univ:Nat Sci , 2020 , 38 ( 6 ): 734 - 740 .
徐继禧 . 六味地黄丸对糖尿病大鼠椎间盘组织退变的影响 [D]. 广州 : 广州中医药大学 , 2022 .
XU J X . Effects of Liuwei Dihuang pills on intervertebral disc degeneration in diabetic rats [D]. Guangzhou : Guangzhou University of Chinese Medicine , 2022 .
张政赢 , 鞠阳 , 刘晓宁 , 等 . 六味地黄丸合二至丸组方联合西医常规治疗对早期糖尿病肾病(肝肾阴虚证)患者的临床疗效观察 [J]. 中国医院用药评价与分析 , 2024 , 24 ( 1 ): 47 - 50 .
ZHANG Z Y , JU Y , LIU X N , et al . Clinical efficacy observation of Liuwei Dihuang pills combined with Erzhi pills plus conventional western medicine treatment for early diabetic nephropathy (liver-kidney Yin deficiency syndrome) [J]. Eval Anal Drug-Use Hosp China , 2024 , 24 ( 1 ): 47 - 50 .
郑红梅 , 黄鹤 , 陆敏 . 六味地黄丸合桃红四物汤加减治疗肝肾阴虚糖尿病肾病疗效分析 [J]. 中医临床研究 , 2022 , 14 ( 9 ): 68 - 70 .
ZHENG H M , HUANG H , LU M . Therapeutic effect analysis of Liuwei Dihuang pills combined with modified Taohong Siwu decoction on diabetic nephropathy with liver-kidney Qin deficiency [J]. Clin J Chin Med , 2022 , 14 ( 9 ): 68 - 70 .
史丽钰 . 补肾益气汤合六味地黄丸治疗糖尿病肾病临床观察 [J]. 中国中医药现代远程教育 , 2020 , 18 ( 1 ): 73 - 74 .
SHI L Y . Clinical observation of Bushen Yiqi decoction combined with Liuwei Dihuang pills in treating diabetic nephropathy [J]. Chin Med Mod Distance Educ China , 2020 , 18 ( 1 ): 73 - 74 .
张家丽 , 徐钊熠 , 马秀宁 . 六味地黄汤加减治疗慢性肾炎110例临床疗效分析 [J]. 中国医药指南 , 2016 , 14 ( 35 ): 195 - 196 .
ZHANG J L , XU Z Y , MA X N . Clinical efficacy analysis of modified Liuwei Dihuang decoction in treating 110 cases of chronic nephritis [J]. Chin Med Guide , 2016 , 14 ( 35 ): 195 - 196 .
刘菊 , 李慧 . 基于古今医案云平台系统分析国医大师治疗肾虚型高血压的用药规律 [J]. 中西医结合心脑血管病杂志 , 2022 , 20 ( 20 ): 3673 - 3676 .
LIU J , LI H . Analysis of medication rules of national medical masters in treating hypertension with kidney deficiency pattern based on ancient and modern medical case cloud platform system [J]. Chin J Integr Med Cardio-Cerebrovasc Dis , 2022 , 20 ( 20 ): 3673 - 3676 .
刘会中 , 孙思怡 , 李党召 , 等 . 六味地黄丸联合恩格列净治疗2型糖尿病的临床研究 [J]. 现代药物与临床 , 2023 , 38 ( 12 ): 3091 - 3096 .
LIU H Z , SUN S Y , LI D Z , et al . Clinical study of Liuwei Dihuang pills combined with empagliflozin in treatment of type 2 diabetes [J]. Drugs Clin , 2023 , 38 ( 12 ): 3091 - 3096 .
姜铭 , 姚锐 , 袁维运 . 针刺联合六味地黄丸加味干预老年卒中伴高血压患者(肝肾阴虚型)的临床观察及对患者血压水平影响 [J]. 中华中医药学刊 , 2026 , 44 ( 3 ): 180 - 184 .
JIANG M , YAO R , YUAN W Y . Clinical observation of acupuncture combined with modified Liuwei Dihuang pills in elderly stroke patients with hypertension (liver-kidney Qin deficiency type) and its effect on blood pressure [J]. Chin Arch Tradit Chin Med , 2026 , 44 ( 3 ): 180 - 184 .
蒋雪蓉 . 六味地黄丸对糖尿病伴有高血脂患者的疗效观察 [J]. 中医临床研究 , 2014 , 6 ( 27 ): 52 - 54 .
JIANG X R . Observation on the efficacy of Liuwei Dihuang pills in diabetic patients with hyperlipidemia [J]. Clin J Chin Med , 2014 , 6 ( 27 ): 52 - 54 .
王新华 , 朱世国 , 丰平 . 六味地黄丸联合雌激素治疗围绝经期综合征的临床效果 [J]. 临床合理用药 , 2023 , 16 ( 22 ): 24 - 26 .
WANG X H , ZHU S G , FENG P . Clinical effect of Liuwei Dihuang pills combined with estrogen in treatment of perimenopausal syndrome [J]. Clin Reasonable Drug Use , 2023 , 16 ( 22 ): 24 - 26 .
陈烨 , 陈超 . 六味地黄丸联合雌二醇地屈孕酮治疗围绝经期综合征的临床研究 [J]. 北方药学 , 2024 , 21 ( 5 ): 56 - 58 .
CHEN Y , CHEN C . Clinical study of Liuwei Dihuang pills combined with estradiol and dydrogesterone in treatment of perimenopausal syndrome [J]. North Pharm J , 2024 , 21 ( 5 ): 56 - 58 .
狄丹华 , 杨准叶 . 紫河车合六味地黄丸治疗青春期多囊卵巢综合征30例临床观察 [J]. 中国医药指南 , 2019 , 17 ( 22 ): 189 - 190 .
DI D H , YANG Z Y . Clinical observation of 30 cases of adolescent polycystic ovary syndrome treated with Ziheche combined with Liuwei Dihuang pills [J]. Chin Med Guide , 2019 , 17 ( 22 ): 189 - 190 .
杨小青 . 加味逍遥丸联合六味地黄丸在肾虚型月经失调患者中的应用 [J]. 河南医学研究 , 2020 , 29 ( 23 ): 4374 - 4375 .
YANG X Q . Application of Jiawei Xiaoyao pills combined with Liuwei Dihuang pills in patients with menstrual disorders of kidney deficiency type [J]. Henan Med Res , 2020 , 29 ( 23 ): 4374 - 4375 .
刘肖林 , 吴梓春 , 戴晖 . 六味地黄丸治疗卵巢早衰的临床效果观察 [J]. 实用妇科内分泌杂志:电子版 , 2019 , 6 ( 1 ): 72 - 73 .
LIU X L , WU Z C , DAI H . Observation on clinical effect of Liuwei Dihuang pills in treatment of premature ovarian failure [J]. J Pract Gynecol Endocrinol:Electron Ed , 2019 , 6 ( 1 ): 72 - 73 .
王璠琛 , 何琪 , 肖嘉聪 , 等 . “肾主骨”理论“髓变先于骨变”的肾-髓-骨调节机制构建 [J]. 中国骨质疏松杂志 , 2023 , 29 ( 9 ): 1354 - 1361 .
WANG F C , HE Q , XIAO J C , et al . Construction of kidney-marrow-bone regulation mechanism of "marrow changes precede bone changes" in "kidney governing bones" theory [J]. Chin J Osteoporos , 2023 , 29 ( 9 ): 1354 - 1361 .
龙穆玲 . 地舒单抗联合六味地黄丸治疗肝肾阴虚型骨质疏松性椎体压缩骨折PVP术后的疗效观察 [D]. 成都 : 成都体育学院 , 2024 .
LONG M L . Observation on the efficacy of denosumab combined with Liuwei Dihuang pills in treatment of osteoporotic vertebral compression fractures with liver-kidney Yin deficiency after PVP [D]. Chengdu : Chengdu Sport University , 2024 .
谭小艳 , 李新华 , 陈光华 , 等 . 六味地黄丸联合唑来膦酸治疗绝经后骨质疏松症患者的临床疗效 [J]. 中国药物经济学 , 2024 , 19 ( 10 ): 47 - 51 .
TAN X Y , LI X H , CHEN G H , et al . Clinical efficacy of Liuwei Dihuang pills combined with zoledronic acid in treatment of postmenopausal osteoporosis [J]. Chin J Drug Econo , 2024 , 19 ( 10 ): 47 - 51 .
白津硕 . 六味地黄丸治疗肝肾阴虚型原发性骨质疏松症临床疗效的荟萃分析 [D]. 沈阳 : 辽宁中医药大学 , 2018 .
BAI J S . Meta-analysis of clinical efficacy of Liuwei Dihuang pills in treatment of primary osteoporosis with liver-kidney yin deficiency [D]. Shenyang : Liaoning University of Traditional Chinese Medicine , 2018 .
张爱群 , 蔡秀莺 , 谢亦娴 . 六味地黄丸治疗肝肾阴虚型原发性骨质疏松症临床疗效分析 [J]. 黑龙江医药 , 2023 , 36 ( 4 ): 870 - 873 .
ZHANG A Q , CAI X Y , XIE Y X . Clinical efficacy analysis of Liuwei Dihuang pills in treatment of primary osteoporosis with liver-kidney yin deficiency [J]. Heilongjiang Med J , 2023 , 36 ( 4 ): 870 - 873 .
安娟 , 匡浩铭 , 李振宇 , 等 . 六味地黄丸治疗2型糖尿病性骨质疏松症的疗效评价 [J]. 湖南中医药大学学报 , 2022 , 42 ( 7 ): 1216 - 1220 .
AN J , KUANG H M , LI Z Y , et al . Efficacy evaluation of Liuwei Dihuang pills in treatment of type 2 diabetic osteoporosis [J]. J Hunan Univ Chin Med , 2022 , 42 ( 7 ): 1216 - 1220 .
许晓霞 , 王亚君 , 喜雷 , 等 . 六味地黄丸联合醋酸亮丙瑞林治疗女童中枢性性早熟的临床研究 [J]. 现代药物与临床 , 2023 , 38 ( 4 ): 878 - 883 .
XU X X , WANG Y J , XI L , et al . Clinical study of Liuwei Dihuang pills combined with leuprorelin acetate in treatment of girls with central precocious puberty [J]. Drugs Clin , 2023 , 38 ( 4 ): 878 - 883 .
饶桂兰 . 六味地黄丸治疗阿尔兹海默病肾阴亏虚证的临床疗效观察 [D]. 长沙 : 湖南中医药大学 , 2024 .
RAO G L . Clinical efficacy observation of Liuwei Dihuang pills in treating Alzheimer's disease with kidney Qin deficiency syndrome [D]. Changsha : Hunan University of Chinese Medicine , 2024 .
ZHANG J P , ZHOU D J . Changes in leucocytic estrogen receptor levels in patients with climacteric syndrome and therapeutic effect of Liuwei Dihuang pills [J]. Zhong Xi Yi Jie He Za Zhi , 1991 , 11 ( 9 ): 521 - 523,515 .
卢秀娥 . 丹栀逍遥散加六味地黄丸加减治疗失眠的疗效观察 [J]. 中国现代药物应用 , 2024 , 18 ( 24 ): 32 - 36 .
LU X E . Clinical efficacy observation of modified Danzhi Xiaoyao powder combined with Liuwei Dihuang pills in treating insomnia [J]. Chin J Mod Drug Appl , 2024 , 18 ( 24 ): 32 - 36 .
温秀珍 , 杨建良 , 陈建平 . 六味地黄丸联合大黄液治疗慢性牙周炎的效果分析 [J]. 中外医药研究 , 2024 , 3 ( 3 ): 78 - 80 .
WEN X Z , YANG J L , CHEN J P . Effect analysis of Liuwei Dihuang pills combined with rhubarb liquid in treating chronic periodontitis [J]. Chin Foreign Med Res , 2024 , 3 ( 3 ): 78 - 80 .
陈荣 , 钟水生 , 王亚琼 , 等 . 六味地黄丸定量分析方法和评价体系的建立 [J]. 中国实验方剂学杂志 , 2024 , 30 ( 16 ): 177 - 184 .
CHEN R , ZHONG S S , WANG Y Q , et al . Establishment of quantitative analysis method and evaluation system for Liuwei Dihuang pills [J]. Chin J Exp Tradit Med Form , 2024 , 30 ( 16 ): 177 - 184 .
邱伊星 . 六味地黄丸及其相关制剂的指纹图谱质量控制方法研究 [D]. 长沙 : 湖南中医药大学 , 2016 .
QIU Y X . Study on fingerprint quality control methods of Liuwei Dihuang pills and its related preparations [D]. Changsha : Hunan University of Chinese Medicine , 2016 .
张雪 , 佟玉良 , 夏天利 , 等 . 六味地黄丸入血、入脑成分分析 [J]. 中成药 , 2023 , 45 ( 11 ): 3534 - 3539 .
ZHANG X , TONG Y L , XIA T L , et al . Analysis of blood-entering and brain-entering components of Liuwei Dihuang pills [J]. Chin Tradit Pat Med , 2023 , 45 ( 11 ): 3534 - 3539 .
王迪 , 张宁 , 陈雪 , 等 . 基于UPLC-LTQ-Orbitrap-MS和网络药理学探讨六味地黄丸治疗AD潜在作用机制 [J]. 药物分析杂志 , 2022 , 42 ( 4 ): 580 - 589 .
WANG D , ZHANG N , CHEN X , et al . Potential mechanism of Liuwei Dihuang pills in treating Alzheimer's disease based on UPLC-LTQ-Orbitrap-MS and network pharmacology [J]. Chin J Pharm Anal , 2022 , 42 ( 4 ): 580 - 589 .
李秋菊 , 王萍 , 王美佳 , 等 . 基于中医方证代谢组学技术的六味地黄丸干预脑瘫大鼠模型研究 [J]. 世界科学技术—中医药现代化 , 2016 , 18 ( 10 ): 1684 - 1696 .
LI Q J , WANG P , WANG M J , et al . Study on Liuwei Dihuang pills intervening cerebral palsy rat model based on traditional Chinese medicine prescription-syndrome metabolomics technology [J]. World Sci Technol-Mod Tradit Chin Med , 2016 , 18 ( 10 ): 1684 - 1696 .
戴冰 , 肖子曾 , 刘磊 , 等 . 六味地黄丸入血成分莫诺苷对大鼠前脂肪细胞增殖与分化的影响 [J]. 中国临床药理学与治疗学 , 2007 ( 11 ): 1245 - 1249 .
DAI B , XIAO Z Z , LIU L , et al . Effects of morroniside,a blood component of Liuwei Dihuang pills,on proliferation and differentiation of rat preadipocytes [J]. Chin J Clin Pharmacol Ther , 2007 ( 11 ): 1245 - 1249 .
张丽先 , 魏悦 , 李飞飞 , 等 . 地黄不同炮制品指纹图谱模式识别及多成分含量测定 [J]. 湖北农业科学 , 2023 , 62 ( 9 ): 135 - 141 .
ZHANG L X , WEI Y , LI F F , et al . Pattern recognition of fingerprint and multi-component content determination of different processed products of Rehmanniae Radix [J]. Hubei Agric Sci , 2023 , 62 ( 9 ): 135 - 141 .
刘昱 . 中药材山茱萸质量标志物和多糖研究 [D]. 天津 : 天津科技大学 , 2022 .
LIU Y . Study on quality markers and polysaccharides of medicinal material Corni Fructus [D]. Tianjin : Tianjin University of Science and Technology , 2022 .
宿婷婷 , 赵旭 , 汪坤 , 等 . 山药的质量控制现状及质量标志物预测分析 [J]. 中国医院药学杂志 , 2025 , 45 ( 12 ): 1424 - 1430 .
SU T T , ZHAO X , WANG K , et al . Current status of quality control and prediction analysis of quality markers for Dioscoreae Rhizoma [J]. Chin J Hosp Pharm , 2025 , 45 ( 12 ): 1424 - 1430 .
常晓燕 . 泽泻汤化学成分及抗非酒精性脂肪肝谱效关系研究 [D]. 北京 : 北京协和医学院 , 2020 .
CHANG X Y . Study on chemical constituents of Alismatis decoction and spectrum-effect relationship against non-alcoholic fatty liver disease [D]. Beijing : Peking Union Medical College , 2020 .
王彩虹 , 邱智东 , 王永春 , 等 . 牡丹皮的现代研究进展及质量标志物预测分析 [J]. 中药材 , 2023 , 46 ( 9 ): 2361 - 2369 .
WANG C H , QIU Z D , WANG Y C , et al . Modern research progress and prediction analysis of quality markers for Moutan Cortex [J]. J Chin Med Mater , 2023 , 46 ( 9 ): 2361 - 2369 .
邓桃妹 , 彭代银 , 俞年军 , 等 . 茯苓化学成分和药理作用研究进展及质量标志物的预测分析 [J]. 中草药 , 2020 , 51 ( 10 ): 2703 - 2717 .
DENG T M , PENG D Y , YU N J , et al . Research progress on chemical constituents and pharmacological effects of Poria and prediction analysis of its quality markers [J]. Chin Tradit Herb Drugs , 2020 , 51 ( 10 ): 2703 - 2717 .
胡汝明 , 谢岳婷 , 陈剑川 . 基于AKT/GSK-3 β 信号通路探讨熟地黄提取物对糖尿病肾病大鼠肾小球脏层上皮细胞表型转化的影响 [J]. 中国老年学杂志 , 2023 , 43 ( 10 ): 2497 - 2500 .
HU R M , XIE Y T , CHEN J C . Effects of Rehmanniae Radix Praeparata extract on phenotypic transformation of glomerular visceral epithelial cells in diabetic nephropathy rats based on AKT/GSK-3 β signaling pathway [J]. Chin J Gerontol , 2023 , 43 ( 10 ): 2497 - 2500 .
Lee H , Lee G , Kim H , et al . Paeonol,a major compound of Moutan Cortex,attenuates cisplatin-induced nephrotoxicity in mice [J]. Evid Based Complement Alternat Med , 2013 , 2013 : 310989 .
赵世杰 , 王文荣 , 王婧一 , 等 . 芍药苷对单侧输尿管梗阻大鼠肾间质纤维化的作用 [J]. 中国中西医结合肾病杂志 , 2018 , 19 ( 11 ): 985 - 987 .
ZHAO S J , WANG W R , WANG J Y , et al . Effect of paeoniflorin on renal interstitial fibrosis in unilateral ureteral obstruction rats [J]. Chin J Integr Tradit West Nephrol , 2018 , 19 ( 11 ): 985 - 987 .
黄小强 , 张雪 , 李小艳 , 等 . 泽泻不同提取部位对大鼠的利尿作用 [J]. 福建中医药 , 2016 , 47 ( 5 ): 21 - 23 .
HUANG X Q , ZHANG X , LI X Y , et al . Diuretic effects of different extracts of Alismatis Rhizoma in rats [J]. Fujian J Tradit Chin Med , 2016 , 47 ( 5 ): 21 - 23 .
王素云 , 卢颖 , 蔡丹凤 , 等 . 基于雌激素受体探讨梓醇对抗糖剥夺心肌细胞损伤的作用 [J]. 中国药理学通报 , 2019 , 35 ( 6 ): 786 - 792 .
WANG S Y , LU Y , CAI D F , et al . Effect of catalpol against glucose deprivation-induced cardiomyocyte injury based on estrogen receptor [J]. Chin Pharmacol Bull , 2019 , 35 ( 6 ): 786 - 792 .
ZHENG T , PENG J , PEI T , et al . Cornel iridoid glycoside exerts a neuroprotective effect on neuroinflammation in rats with brain injury by inhibiting NF-kappaB and STAT3 [J]. 3 Biotech , 2019 , 9 ( 5 ): 195 .
ZHANG B , YU D , LUO N , et al . Four active monomers from Moutan Cortex exert inhibitory effects against oxidative stress by activating Nrf2/Keap1 signaling pathway [J]. Korean J Physiol Pharmacol , 2020 , 24 ( 5 ): 373 - 384 .
江薇 . 茯苓酸通过激活多聚腺苷二磷酸核糖聚合酶诱导人乳腺癌细胞MDA-MB-231凋亡 [J]. 中草药 , 2016 , 47 ( 21 ): 3861 - 3865 .
JIANG W . Poriaic acid induces apoptosis of human breast cancer cells MDA-MB-231 by activating poly ADP-ribose polymerase [J]. Chin Tradit Herb Drugs , 2016 , 47 ( 21 ): 3861 - 3865 .
董建设 , 赵俊峰 , 张林超 , 等 . 茯苓酸通过Wnt信号通路对肾癌细胞生物学特性的影响 [J]. 中国老年学杂志 , 2019 , 39 ( 9 ): 2241 - 2244 .
DONG J S , ZHAO J F , ZHANG L C , et al . Effects of poriaic acid on biological characteristics of renal carcinoma cells through Wnt signaling pathway [J]. Chin J Gerontol , 2019 , 39 ( 9 ): 2241 - 2244 .
Lee S , Lee S , Roh HS , et al . Cyto toxic constituents from the sclerotia of Poria cocos against human lung adenocarcinoma cells by inducing mitochondrial apoptosis [J]. Cells , 2018 , 7 ( 9 ): 116 .
刘文斌 , 高杨 , 王艳良 , 等 . 松果菊苷通过性别决定区Y框蛋白4对胃癌AGS细胞增殖和凋亡的影响研究 [J]. 中国药师 , 2021 , 24 ( 6 ): 1064 - 1069 .
LIU W B , GAO Y , WANG Y L , et al . Effects of echinacoside on proliferation and apoptosis of gastric cancer AGS cells through sex determining region Y-box protein 4 [J]. China Pharm , 2021 , 24 ( 6 ): 1064 - 1069 .
TIAN H , LIU Z , PU Y , et al . Immunomodulatory effects exerted by Poria cocos polysaccharides via TLR4/TRAF6/NF- κ B signaling in vitro and in vivo [J]. Biomed Pharmacother , 2019 , 112 : 108709 .
徐倩倩 , 杨万群 , 王玉波 , 等 . 熟地黄多糖对环磷酰胺诱导的免疫抑制小鼠的免疫调节作用研究 [J]. 中国畜牧兽医 , 2023 , 50 ( 2 ): 693 - 703 .
XU Q Q , YANG W Q , WANG Y B , et al . Immunomodulatory effects of Rehmanniae Radix Praeparata Polysaccharides on cyclophosphamide-induced immunosuppressed mice [J]. China Anim Husb Vet Med , 2023 , 50 ( 2 ): 693 - 703 .
LIN C , WANG B , FANG W , et al . Catalpol ameliorates neointimal hyperplasia in diabetic rats [J]. Planta Med , 2019 , 85 ( 5 ): 406 - 411 .
ZHOU Y , LI R , ZHENG Y , et al . Diosgenin ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and related lipid/amino acid metabolism in high fat diet-fed rats [J]. Front Pharmacol , 2022 , 13 : 854790 .
张慧康 , 于淼 , 周计春 . 六味地黄丸“三泻”药辨疑 [J]. 中国中医基础医学杂志 , 2022 , 28 ( 2 ): 280 - 282 .
ZHANG H K , YU M , ZHOU J C . Discussion on the "three draining herbs" in Liuwei Dihuang pills [J]. Chin J Basic Med Tradit Chin Med , 2022 , 28 ( 2 ): 280 - 282 .
王萌萌 , 方健 , 栾相佳 , 等 . 基于“肠-肾轴”的泽泻致肾损伤及在六味地黄丸配伍中的肾脏保护机制研究 [J]. 中华中医药学刊 , 2026 , 44 ( 1 ):121-127, 268 - 271 .
WANG M M , FANG J , LUAN X J , et al . Renal injury induced by Alismatis Rhizoma based on "gut-kidney axis" and renal protection mechanism in Liuwei Dihuang pills compatibility [J]. Chin Arch Tradit Chin Med , 2026 , 44 ( 1 ):121-127, 268 - 271 .
邢志政 . 熟地黄-山药-山茱萸治疗肾阴虚少精子症作用机制及药效物质基础研究 [D]. 西安 : 中国人民解放军空军军医大学 , 2024 .
XING Z Z . Mechanism and pharmacodynamic material basis of Rehmanniae Radix Praeparata-Dioscoreae Rhizoma-Corni Fructus in treating oligospermia with kidney Yin deficiency [D]. Xi'an : Air Force Medical University , 2024 .
王旭 , 许原 , 管亚男 , 等 . 熟地黄-山茱萸药对通过PI3K/AKT通路对A β 25-35诱导的N2a细胞凋亡的影响 [J]. 辽宁中医杂志 , 2024 , 51 ( 2 ): 151 - 154 .
WANG X , XU Y , GUAN Y N , et al . Effects of Rehmanniae Radix Praeparata-Corni Fructus herb pair on A β 25-35-induced apoptosis of N2a cells via PI3K/AKT pathway [J]. Liaoning J Tradit Chin Med , 2024 , 51 ( 2 ): 151 - 154 .
白颖锋 , 李雪梅 , 韩笑 , 等 . 基于综合生物信息学筛选山茱萸-牡丹皮抗肝损伤潜在活性成分及靶点 [J]. 中国药理学通报 , 2020 , 36 ( 11 ): 1615 - 1621 .
BAI Y F , LI X M , HAN X , et al . Screening potential active components and targets of Corni Fructus-Moutan Cortex against liver injury based on comprehensive bioinformatics [J]. Chin Pharmacol Bull , 2020 , 36 ( 11 ): 1615 - 1621 .
耿丽 , 蔡云芳 . 六味地黄丸HPLC指纹图谱建立及主要成分分析 [J]. 世界中医药 , 2019 , 14 ( 11 ): 2875 - 2878 .
GENG L , CAI Y F . Establishment of HPLC fingerprint and analysis of main components of Liuwei Dihuang pills [J]. World Chin Med , 2019 , 14 ( 11 ): 2875 - 2878 .
代磊 , 李艳 , 侯媛芳 , 等 . 电感耦合等离子体质谱法结合化学计量学分析六味地黄丸中23种元素 [J]. 理化检验-化学分册 , 2023 , 59 ( 7 ): 798 - 805 .
DAI L , LI Y , HOU Y F , et al . Analysis of 23 elements in Liuwei Dihuang pills by inductively coupled plasma mass spectrometry combined with chemometrics [J]. Phys Test Chem Anal (Chem Anal) , 2023 , 59 ( 7 ): 798 - 805 .
易子漾 , 陈林 , 郝婧 , 等 . 六味地黄丸指纹图谱和抗氧化活性的“谱-效”关系研究 [J]. 中华中医药杂志 , 2022 , 37 ( 7 ): 4096 - 4101 .
YI Z Y , CHEN L , HAO J , et al . Study on "spectrum-effect" relationship between fingerprint and antioxidant activity of Liuwei Dihuang pills [J]. China J Tradit Chin Med Pharm , 2022 , 37 ( 7 ): 4096 - 4101 .
国家药品监督管理局 . 国家药品监督管理局关于发布《古代经典名方中药复方制剂简化注册审批管理规定》的公告(2018年第27号) [EB/OL].( 2018-06-01 )[ 2025-04-26 ]. https://www.nmpa.gov.cn/zhuanti/ypqxgg/ggzhcfg/20180601163901361.html https://www.nmpa.gov.cn/zhuanti/ypqxgg/ggzhcfg/20180601163901361.html .
National Medical Products Administration . Announcement of National Medical Products Administration on issuing "Provisions for Simplified Registration and Approval of Traditional Chinese Medicine Compound Preparations Derived from Ancient Classical Prescriptions" (No.27 of 2018 )[EB/OL].( 2018-06-01 )[ 2025-04-26 ]. https://www.nmpa.gov.cn/zhuanti/ypqxgg/ggzhcfg/20180601163901361.html https://www.nmpa.gov.cn/zhuanti/ypqxgg/ggzhcfg/20180601163901361.html .
刘昌孝 . 中药质量标志物(Q-Marker)研究发展的5年回顾 [J]. 中草药 , 2021 , 52 ( 9 ): 2511 - 2518 .
LIU C X . A five-year review of the research and development of quality markers (Q-Marker) for traditional Chinese medicine [J]. Chin Tradit Herb Drug , 2021 , 52 ( 9 ): 2511 - 2518 .
陈雨嘉 , 李晓欣 , 姜宇 , 等 . 基于UPLC-Q-TOF-MS的地黄清蒸、酒炖过程成分变化分析 [J]. 中国现代中药 , 2026 , 28 ( 1 ): 143 - 149 .
CHEN Y J , LI X X , JIANG Y , et al . Analysis of component changes during steaming and wine-steaming processes of Rehmanniae Radix using UPLC-Q-TOF-MS [J]. Modern Chin Med , 2026 , 28 ( 1 ): 143 - 149 .
0
Views
1
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621